Biotechnology Value Fund, which holds a 30 percent stake in Avigen, will finally get that special shareholders meeting it's been pushing for later this month. The firm is urging fellow stockholders to ...

District 8 City Council Member Manny Peláez and his law firm are on trial this week in U.S. Bankruptcy Court in San Antonio over whether they stiffed a business that provided property damage appraisal ...

District 8 City Councilman Manny Peláez and his law firm have been sued by a bankruptcy trustee in a Chapter 11 case of a business that provided property damage appraisal reports related to insurance ...

ALAMEDA, Calif., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today said its Board of Directors rejected the unsolicited conditional offer from BVF ...

Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.

ZURICH, SWITZERLAND / ACCESSWIRE / December 14, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP,)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the ...

This might explain why BVF Partners chose to sell at this time, potentially capitalizing on the stock's recent gains while the company maintains a solid cash position. However, it's worth noting that ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

SOUTH SAN FRANCISCO, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it ...